ILK and prostate carcinoma: Not only this one study, but there are tens of thousands such studies like this, such as a recent study first utilized bioinformatics pipeline comprising different techniques to experimentally validate the ILK gene against prostate cancer using shRNA transfection, qPCR, and western blotting [62].